Clinical trial
GIMEMA LAL 0496: High-dose Anthracycline in the Induction Regimen for the…
NCT00439920 · Gruppo Italiano Malattie EMatologiche dell'Adulto, Other · Unknown status
Key facts
| NCT number | NCT00439920 |
|---|---|
| Title | GIMEMA LAL 0496: High-dose Anthracycline in the Induction Regimen for the Treatment of Adult ALL. |
| Official title | GIMEMA LAL 0496: High-dose Anthracycline in the Induction Regimen for the Treatment of Adult Acute Lymphoblastic Leukemia. A Prospective Multicentric GIMEMA Trial. |
| Lead sponsor | Gruppo Italiano Malattie EMatologiche dell'Adulto, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Acute Lymphoblastic Leukemia |
| Intervention type | Drug |
| Interventions | High-dose anthracycline |
| Start date | Oct 1, 1996 |
| Primary completion | Dec 1, 2018 |
| Completion | Dec 1, 2018 |
| First posted | Feb 26, 2007 |
| Last update posted | Oct 23, 2018 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: